Oppenheimer Downgrades The Medicines Company (MDCO) to Perform
Oppenheimer analyst Jay Olson downgraded The Medicines Company (NASDAQ: MDCO) from ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
